Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: April 19, 2005
Healers Abroad: Americans Responding to the Human Resource Crisis in HIV/AIDS, recommends that the federal government create and fund an umbrella organization called the United States Global Health Service (GHS) to mobilize the nation's best health care professionals and other experts to help combat HIV/AIDS in hard-hit African, Caribbean, and Southeast Asian countries.
Released: April 18, 2005
Continued improvements in survival of childhood and adolescent cancer and less toxic outcomes will be achieved only with new chemical and biological agents. Despite a wealth of tantalizing leads from basic science, there is a near-complete void in commercial R&D for pediatric cancer. There is another way to harness the disparate activities already in existence to discover and develop new drugs for pediatric cancers. Making Better Drugs for Children with Cancer describes a practical approach to joining the capabilities of the National Institutes of Health, academic laboratories, and the pharmaceutical industry in a virtual R&D network.
Released: April 06, 2005
Assessing the Quality of Cancer Care: An Approach to Measurement in Georgia describes and recommends a set of 52 quality indicators with which the Georgia Cancer Coalition can measure Georgia's progress in improving cancer care and reducing the number of cancer cases and deaths.
Released: March 03, 2005
This report discusses lessons learned from the smallpox vaccination program, concludes that there is a need to balance scientific communication with national security imperatives in the context of such programs, and recommends that smallpox preparedness should be comprehensively assessed.
Released: February 17, 2005
This report is a summary of the workshop, "Economic Models of Colorectal Cancer Screening in Average-Risk Adults" that was held by the Institute of Medicine's National Cancer Policy Board on January 26-27, 2004, to explore the reasons for differences among leading cost-effectiveness analysis models of CRC screening.
Released: November 16, 2004
There has been increased concern about the prospect of an influenza pandemic, which many experts believe to be inevitable. Yet the general public does not appear to share this perception, especially in the shadow of equally scary but less likely risks of a bioterrorist attack. Moreover, recent problems with the availability and strain-specificity of vaccine for annual flu epidemics in some countries and the rise of pandemic strains of avian flu in disparate geographic regions have alarmed experts about the world's ability to prevent or contain a human pandemic. The workshop summary, The Threat of Pandemic Influenza: Are We Ready? A Workshop Summary, addresses this urgent concern.
Released: September 29, 2004
In response to a request from Congress for a prevention-oriented action plan to tackle the alarming rise in childhood obesity, the IOM Committee on Prevention of Obesity in Children and Youth has developed a comprehensive national strategy that recommends specific actions for families, schools, industry, communities, and government. The committee's findings and recommendations are described in the report Preventing Childhood Obesity: Health in the Balance.
Released: September 14, 2004
On January 6 and 7, 2004, the Institute of Medicine (IOM) hosted the 1st Annual Crossing the Quality Chasm Summit, convening a diverse group of national and community health care leaders to pool their knowledge and resources with regard to strategies for improving patient care for five common chronic illnesses: asthma, depression, diabetes, heart failure, and pain control in advanced cancer.
Released: July 28, 2004
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects assists policymakers in evaluating the appropriate scientific methods for detecting unintended changes in food and assessing the potential for adverse health effects from genetically modified products. In this report, the committee recommended that greater scrutiny should be given to foods containing new compounds or unusual amounts of naturally occurring substances, regardless of the method used to create them.
Released: July 07, 2004
An estimated forty million people carry the human immunodeficiency virus (HIV), and five million more become newly infected annually. In recent years, many HIV-infected patients in wealthy nations have eAffiliateMarketIngtoolsed significantly longer, good-quality lives as a result of antiretroviral therapy (ART). However, most infected individuals live in the poorest regions of the world, where ART is virtually nonexistent. The consequent death toll in these regions--especially sub-Saharan Africa--is begetting economic and social collapse. To inform the multiple efforts underway to deploy antiretroviral drugs in resource-poor settings, the Institute of Medicine committee was asked to conduct an independent review and assessment of rapid scale-up ART programs.